Winton Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,555
Closed -$997K 731
2025
Q2
$997K Buy
+9,555
New +$1.01M 0.05% 437
2024
Q3
Sell
-8,823
Closed -$710K 624
2024
Q2
$710K Buy
8,823
+5,385
+157% +$399K 0.05% 380
2024
Q1
$274K Buy
+3,438
New +$289K 0.02% 536
2023
Q3
Sell
-5,179
Closed -$372K 771
2023
Q2
$372K Sell
5,179
-7,655
-60% -$565K 0.03% 441
2023
Q1
$792K Buy
12,834
+328
+3% +$21.5K 0.05% 528
2022
Q4
$965K Sell
12,506
-1,456
-10% -$87K 0.06% 417
2022
Q3
$623K Sell
13,962
-3,847
-22% -$192K 0.04% 575
2022
Q2
$682K Buy
17,809
+1,465
+9% +$46.3K 0.04% 611
2022
Q1
$676K Buy
16,344
+2,335
+17% +$72.4K 0.04% 593
2021
Q4
$529K Buy
14,009
+4,309
+44% +$159K 0.03% 664
2021
Q3
$320K Sell
9,700
-3,072
-24% -$120K 0.02% 1064
2021
Q2
$862K Buy
12,772
+2,111
+20% +$127K 0.05% 608
2021
Q1
$604K Buy
10,661
+3,901
+58% +$274K 0.03% 773
2020
Q4
$551K Sell
6,760
-23,082
-77% -$1.73M 0.04% 742
2020
Q3
$2.13M Buy
29,842
+1,807
+6% +$141K 0.07% 497
2020
Q2
$2.31M Sell
28,035
-1,254
-4% -$96.5K 0.06% 585
2020
Q1
$1.72M Sell
29,289
-198,237
-87% -$16.2M 0.05% 623
2019
Q4
$23.5M Buy
+227,526
New +$9.19M 0.33% 28

Other funds holding AXSM